Skip links
Companies
› United States › VERTEX PHARMACEUTICALS INCORPORATED

VERTEX PHARMACEUTICALS INCORPORATED

Public Limited Company Active

in

Registration No.
043039129
Incorporation Date
1989-01-04
Company Type
Public Limited Company
Address
United States
Website
N/A
Source: Massachusetts Secretary of the Commonwealth

VERTEX PHARMACEUTICALS INCORPORATED is a Public Limited Company registered in United States under 043039129, and its current status with Massachusetts Secretary of the Commonwealth is active. The company was incorporated on 4 January 1989 and lists its registered address as United States. No shareholders are recorded for VERTEX PHARMACEUTICALS INCORPORATED; ownership in this jurisdiction is held as the stock ledger under state corporate law (e.g. §219 of the Delaware General Corporation Law), a record kept privately rather than filed publicly. No beneficial owner (UBO) data is recorded for VERTEX PHARMACEUTICALS INCORPORATED; access to beneficial-ownership data in this jurisdiction is governed by its own register rules. This profile is sourced directly from Massachusetts Secretary of the Commonwealth and was last updated on 24 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Massachusetts Secretary of the Commonwealth.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Need the full UBO picture on VERTEX PHARMACEUTICALS INCORPORATED?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who is VERTEX PHARMACEUTICALS INCORPORATED's UBO (Ultimate Beneficial Owner)?

No Ultimate Beneficial Owner (UBO) data is recorded for VERTEX PHARMACEUTICALS INCORPORATED; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.

What is VERTEX PHARMACEUTICALS INCORPORATED's company registration number?

VERTEX PHARMACEUTICALS INCORPORATED's registration number is 043039129, filed with Massachusetts Secretary of the Commonwealth in United States. Its current status on the register is active.

Is VERTEX PHARMACEUTICALS INCORPORATED still an active company?

VERTEX PHARMACEUTICALS INCORPORATED's status on Massachusetts Secretary of the Commonwealth is listed as active.

When was VERTEX PHARMACEUTICALS INCORPORATED incorporated?

VERTEX PHARMACEUTICALS INCORPORATED was incorporated on 4 January 1989, according to Massachusetts Secretary of the Commonwealth.

What is VERTEX PHARMACEUTICALS INCORPORATED's registered address?

The registered address on file for VERTEX PHARMACEUTICALS INCORPORATED is United States.

What legal structure is VERTEX PHARMACEUTICALS INCORPORATED registered as?

VERTEX PHARMACEUTICALS INCORPORATED is registered as a Public Limited Company in United States.

Can Zavia monitor changes to VERTEX PHARMACEUTICALS INCORPORATED's ownership over time?

This profile reflects a point-in-time snapshot from Massachusetts Secretary of the Commonwealth. Zavia's monitoring API can track changes to VERTEX PHARMACEUTICALS INCORPORATED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access VERTEX PHARMACEUTICALS INCORPORATED's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like VERTEX PHARMACEUTICALS INCORPORATED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Massachusetts Secretary of the Commonwealth and was last synced on 24 September 2026.

This website uses cookies to improve your web experience.